vs
Advantage Solutions Inc.（ADV）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Advantage Solutions Inc.的季度营收约是Royalty Pharma plc的1.5倍（$932.1M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -17.4%，领先51.8%），Royalty Pharma plc同比增速更快（4.8% vs 4.5%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 4.0%）
该公司是一家全球数据与分析企业，为众多行业提供数据技术服务、分析工具、预测洞察与欺诈防范方案，总部位于佐治亚州阿尔法利塔，在美国全境以及澳大利亚、巴西、中国、法国、中国香港、印度、爱尔兰、以色列、菲律宾、英国均设有办公地点。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ADV vs RPRX — 直观对比
营收规模更大
ADV
是对方的1.5倍
$622.0M
营收增速更快
RPRX
高出0.3%
4.5%
净利率更高
RPRX
高出51.8%
-17.4%
两年增速更快
RPRX
近两年复合增速
4.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $932.1M | $622.0M |
| 净利润 | $-161.7M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | -17.4% | 62.4% |
| 净利率 | -17.4% | 34.4% |
| 营收同比 | 4.5% | 4.8% |
| 净利润同比 | 9.2% | 2.9% |
| 每股收益（稀释后） | — | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADVRPRX
| Q4 25 | $932.1M | $622.0M | ||
| Q3 25 | $915.0M | $609.3M | ||
| Q2 25 | $873.7M | $578.7M | ||
| Q1 25 | $821.8M | $568.2M | ||
| Q4 24 | $892.3M | $593.6M | ||
| Q3 24 | $939.3M | $564.7M | ||
| Q2 24 | $873.4M | $537.3M | ||
| Q1 24 | $861.4M | $568.0M |
净利润ADVRPRX
| Q4 25 | $-161.7M | $214.2M | ||
| Q3 25 | $20.6M | $288.2M | ||
| Q2 25 | $-30.4M | $30.2M | ||
| Q1 25 | $-56.1M | $238.3M | ||
| Q4 24 | $-178.0M | $208.2M | ||
| Q3 24 | $-42.8M | $544.0M | ||
| Q2 24 | $-100.8M | $102.0M | ||
| Q1 24 | $-5.3M | $4.8M |
营业利润率ADVRPRX
| Q4 25 | -17.4% | 62.4% | ||
| Q3 25 | 4.4% | 70.1% | ||
| Q2 25 | 1.1% | 36.3% | ||
| Q1 25 | -1.8% | 94.0% | ||
| Q4 24 | -19.1% | 60.9% | ||
| Q3 24 | -0.3% | — | ||
| Q2 24 | -10.4% | 50.2% | ||
| Q1 24 | -3.5% | -13.0% |
净利率ADVRPRX
| Q4 25 | -17.4% | 34.4% | ||
| Q3 25 | 2.2% | 47.3% | ||
| Q2 25 | -3.5% | 5.2% | ||
| Q1 25 | -6.8% | 41.9% | ||
| Q4 24 | -20.0% | 35.1% | ||
| Q3 24 | -4.6% | 96.3% | ||
| Q2 24 | -11.5% | 19.0% | ||
| Q1 24 | -0.6% | 0.8% |
每股收益（稀释后）ADVRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | $-0.13 | $1.21 | ||
| Q2 24 | $-0.31 | $0.23 | ||
| Q1 24 | $-0.02 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $240.8M | $618.7M |
| 总债务越低越好 | $1.7B | $9.0B |
| 股东权益账面价值 | $554.0M | $9.7B |
| 总资产 | $2.8B | $19.6B |
| 负债/权益比越低杠杆越低 | 3.05× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ADVRPRX
| Q4 25 | $240.8M | $618.7M | ||
| Q3 25 | $201.1M | $938.9M | ||
| Q2 25 | $102.9M | $631.9M | ||
| Q1 25 | $121.1M | $1.1B | ||
| Q4 24 | $205.2M | $929.0M | ||
| Q3 24 | $196.1M | $950.1M | ||
| Q2 24 | $154.0M | $1.8B | ||
| Q1 24 | $112.3M | $843.0M |
总债务ADVRPRX
| Q4 25 | $1.7B | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $1.7B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益ADVRPRX
| Q4 25 | $554.0M | $9.7B | ||
| Q3 25 | $708.5M | $9.6B | ||
| Q2 25 | $683.6M | $9.5B | ||
| Q1 25 | $695.6M | $9.8B | ||
| Q4 24 | $748.7M | $10.3B | ||
| Q3 24 | $932.5M | $10.3B | ||
| Q2 24 | $973.7M | $9.8B | ||
| Q1 24 | $1.1B | $9.9B |
总资产ADVRPRX
| Q4 25 | $2.8B | $19.6B | ||
| Q3 25 | $3.0B | $19.3B | ||
| Q2 25 | $3.0B | $18.3B | ||
| Q1 25 | $3.0B | $17.6B | ||
| Q4 24 | $3.1B | $18.2B | ||
| Q3 24 | $3.4B | $18.0B | ||
| Q2 24 | $3.5B | $17.7B | ||
| Q1 24 | $3.6B | $16.1B |
负债/权益比ADVRPRX
| Q4 25 | 3.05× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 2.30× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $23.4M | — |
| 自由现金流率自由现金流/营收 | 2.5% | — |
| 资本支出强度资本支出/营收 | 2.4% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $10.7M | — |
8季度趋势，按日历期对齐
经营现金流ADVRPRX
| Q4 25 | $45.6M | $827.1M | ||
| Q3 25 | $63.6M | $702.6M | ||
| Q2 25 | $-8.1M | $364.0M | ||
| Q1 25 | $-39.6M | $596.1M | ||
| Q4 24 | $15.1M | $742.5M | ||
| Q3 24 | $34.0M | $703.6M | ||
| Q2 24 | $53.4M | $658.2M | ||
| Q1 24 | $-9.4M | $664.6M |
自由现金流ADVRPRX
| Q4 25 | $23.4M | — | ||
| Q3 25 | $52.2M | — | ||
| Q2 25 | $-10.2M | — | ||
| Q1 25 | $-54.7M | — | ||
| Q4 24 | $-27.4M | — | ||
| Q3 24 | $8.6M | — | ||
| Q2 24 | $43.8M | — | ||
| Q1 24 | $-24.8M | — |
自由现金流率ADVRPRX
| Q4 25 | 2.5% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | -1.2% | — | ||
| Q1 25 | -6.7% | — | ||
| Q4 24 | -3.1% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 5.0% | — | ||
| Q1 24 | -2.9% | — |
资本支出强度ADVRPRX
| Q4 25 | 2.4% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.8% | — |
现金转化率ADVRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 3.09× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADV
| Experiential Services | $395.9M | 42% |
| Branded Services | $289.8M | 31% |
| Retailer Services | $246.5M | 26% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
